Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hyperthermia 22 Sarcoma 8 Uterine Cervical Neoplasms 7 Breast Neoplasms 6 Rectal Neoplasms 5 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Colonic Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Urinary Bladder Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Sarcoma, Synovial 2 Neurofibrosarcoma 2 Liver Neoplasms 2 Liposarcoma 2 Leiomyosarcoma 2 Histiocytoma, Malignant Fibrous 2 Fibrosarcoma 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1

Interventions

Capecitabine 20 Oxaliplatin 13 Irinotecan 8 spartalizumab 6 tislelizumab 4 Radiation 4 Neoadjuvant Therapy 4 Immune Checkpoint Inhibitors 4 Fluorouracil 4 toripalimab 3 sintilimab 2 camrelizumab 2 Radiotherapy 2 Leucovorin 2 Celecoxib 2 veliparib 1 peposertib 1 nimotuzumab 1 irinotecan sucrosofate 1 XELOX 1 Thymalfasin 1 Radiotherapy, Intensity-Modulated 1 Injections 1 HMPL-013 1 Folfox protocol 1 Diathermy 1 Combined Modality Therapy 1 Chemoradiotherapy 1 Amifostine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer × Diathermy × Clear all

NCT02290574 2019-11-01

NEOTREAT

Samsung Medical Center

Phase NA Terminated

14 enrolled 7 charts

Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡